A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer

NCT00411788 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Rapamycin
DRUG: Trastuzumab

Sponsor

Yale University

Collaborators

[object Object]